Dr. Christopher L. Vendryes, MD, MS

Dr. Vendryes practices at Urology Medical Specialists, PA in Delray Beach, Florida.

Dr. Vendryes' NPI, 1457663924, was assigned on July 13, 2010. Dr. Vendryes graduated from University of Miami, Miller School of Medicine in 2006. Dr. Vendryes holds Florida license ME 130064.

Dr. Vendryes' primary practice is Urology Medical Specialists, PA, at 5258 Linton Blvd, Delray Beach, FL 33484 in Palm Beach County. The practice phone is (954) 943-1133.

Dr. Vendryes' primary practice is Urology Medical Specialists, PA in Delray Beach, Florida. Dr. Vendryes is also affiliated with Delray Medical Center. The medical group on file is Urology Medical Specialists. Dmand AI also links Dr. Vendryes to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vendryes practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Vendryes' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Vendryes is board certified in urology by the American Board of Urology. Dmand AI has Dr. Vendryes' licenses on file in 3 states: Florida, California and Illinois.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Vendryes treats.

CMS data shows 2,225 Medicare services from Dr. Vendryes across 15 procedure codes in 2024, for 668 Medicare patients. Medicare paid $157,281 for them.

CMS counts 668 Medicare patients who saw Dr. Vendryes in 2024. The largest group is 75 to 84, with 276 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vendryes' median patient age at 71, with 26% women.

In 2024, Dr. Vendryes wrote 1,847 Medicare Part D claims for 627 patients. 89% of them were for generic drugs. CMS names the drug for 1,715 of them, across 26 drugs with 11 or more claims each, at $209,053 in total drug cost. In 2023, CMS named 1,893 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Vendryes for performance year 2024, reported individually. Dr. Vendryes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vendryes as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Vendryes. Dr. Vendryes' most frequent co-authors are Tomoaki Kato, MD, Gwenn E. Mclaughlin, MD and Rita L. Romaguera.

CMS Open Payments shows 209 general payments to Dr. Vendryes from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. Boston Scientific Corporation paid the most, $3,604.

Dr. Vendryes graduated from University of Miami, Miller School of Medicine in 2006.

Dr. Vendryes is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.